Research funder · United States
Michael J. Fox Foundation for Parkinson's Research
Non-profit organization in the USA
- Grants since 2016
- 1 275
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 3 085
- Funded works, all time
- 6 716
Grants
2018 · research · Mitochondrial Biomarkers Program
Novel Mitochondrial Biomarkers in Genetically Stratified Parkinson's Disease Patients
Christine Klein · University Of Lubeck; University Hospital Of Schleswig-holstein
2018 · research · Research Grant
Searching for New Genes That Control Mitochondrial Self-Eating
J. Wade Harper · Harvard University
2018 · research · Access to Data and Biospecimens
Discovery and Verification of Parkinson's Disease Biomarkers
Daniel Chelsky · Caprion Biosciences Inc.
2018 · research · Biomarkers Across Neurodegenerative Diseases
Brain Networks as Targets of Neurodegeneration in Parkinson's and Alzheimer's Diseases
Alain Dagher · McGill University
2018 · research · Access to Data and Biospecimens
Studying Methylation in the PPMI Cohort to Develop New Biomarkers
Travis Dunckley · Arizona State University
2018 · research · Research Grant
PAK6 Activity as a Therapeutic Target in LRRK2-associated Parkinson's Disease
Elisa Greggio · University of Padua
2018 · research · Inflammation Biomarkers Program
Using Changes in Immune Cells to Diagnose or Track Parkinson's Disease
Towfique Raj · Icahn School of Medicine at Mount Sinai
2018 · research · Research Grant
The Role of LRRK2 in Immune Response and Neurodegeneration Caused by Mitochondrial Dysfunction
Richard J. Youle · National Institutes of Health
2018 · research · GBA Biology and Therapies
Assessing TRPML1 Agonists in GBA Parkinson’s Disease
Magdalene M. Moran · Caraway Therapeutics, Inc.
2018 · research · Research Grant
A Global Search for People with a Rare, Inherited Form of Parkinson's Disease
Christine Klein · University Of Lubeck; University Hospital Of Schleswig-holstein
2018 · research · Alpha-Synuclein Biology
Using Powerful Metabolomic Methods to Identify Blood-based Biomarkers of Early-Stage Parkinson's Disease
Stewart Francis Graham · Oakland University
2018 · research · Alpha-Synuclein Biology and Therapies
Studying the Function of Modified Alpha-synuclein in Health and Disease
Natalie Landeck · National Institutes of Health
2018 · research · Research Grant
Analysis of the LRRK2-Rab Signaling Pathway
Dario Alessi · MRC Protein Phosphorylation and Ubiquitylation Unit
2018 · research · Target Advancement Program
Causes, Mechanism and Consequences of an Energy Crisis in Striatal Nerve Endings
Kelly Lynn Stauch · University of Nebraska Medical Center
2018 · research · Research Grant
Searching for New Causes of LRRK2-associated Parkinson's Disease
Andrew West · Duke University
2018 · research · Target Advancement Program
Searching for and Targeting Calcium Channels that Control Alpha-synuclein Release
Evangelia Emmanouilidou · National and Kapodistrian University of Athens
2018 · research · Research Grant
Assessing the Effects of Parkin Activation in Pre-clinical Models
Richard J. Youle · National Institute of Neurological Disorders and Stroke
2018 · research · Alpha-Synuclein Biology and Therapies
Sugars Cause Alpha-Synuclein to Form Less-Toxic Clumps
Matthew R. Pratt · University of Southern California
2018 · research · Research Grant
Developing TLR2-Blocking Drugs to Reduce Alpha-synuclein-Induced Inflammation in Parkinson's Disease
Diana L. Price · Neuropore Therapies, Inc.
2018 · research · Research Grant
Evaluating the Therapeutic Potential of the Systemic Antagonism of Dopamine Receptor D3
Rodrigo Pacheco · Fundación Ciencia and Vida
2018 · research · Improved Biomarkers and Clinical Outcome Measures
Searching for Signs of Parkinson's Disease in the Eye
Stella Sarraf · Amydis (United States)
2018 · research · Inflammation Biomarkers Program
Influence of Inflammation on Symptoms and Progression of Parkinson's Disease
Kathrin Brockmann · Department Of Neurodegeneration, Hertie-institute For Clinical Brain Research
2018 · research · Target Advancement Program
Studying GLP1 Receptor as a Therapeutic Target in Parkinson's Disease
Sonia Gandhi · Ucl & The Francis Crick Institute
2018 · research · Research Grant
Development of Experimental Setups Using New Antibodies to Detect Alpha-synuclein in Cerebrospinal Fluid
Hilal A. Lashuel · École Polytechnique Fédérale de Lausanne
2018 · research · Target Advancement Program
Searching for Cellular Changes Associated with PINK1 and PRKN Mutations
Fabienne C. Fiesel · Mayo Clinic
2018 · research · Target Advancement Program
Interactions Between Alpha-synuclein and Glycoproteins as a Therapeutic Target
Anna Elizabeth Rhoades · University of Pennsylvania
2018 · research · Research Grant
Assess p935 LRRK2 and Total LRRK2 Levels Using an MSD Assay in Whole Blood
Sarah Huntwork-Rodriguez · Denali Therapeutics, Inc.
2018 · research · LRRK2 Biology Consortium
Developing Cell-Based Tools for the Evaluation of LRRK2 Inhibitors
Sabine Hilfiker · Rutgers, The State University of New Jersey
2018 · research · Target Advancement Program
Evaluation of PARIS ASOs in Models of Parkinson's Disease
Ted M. Dawson · Johns Hopkins University
2018 · research · Research Grant
Optimization of Probe-ELISA Parkin Activity Assay
Satpal Virdee · University of Dundee
2018 · research · Research Grant
Purine Biomarkers of LRRK2-Associated Parkinson's Disease
Michael A. Schwarzschild · Massachusetts General Hospital
2018 · research · Research Grant
Exploring the Mechanisms of Neuropathology in D620N VPS35 Knockin Mice
Darren J. Moore · Van Andel Institute
2018 · research · Research Grant
Using Deep Learning to Evaluate Changes Associated with Parkinson’s Disease
Steven Finkbeiner · University of California, San Francisco
2018 · research · Research Grant
URMC-099 in an In Vivo AAV-hSYN Model of Parkinson’s Disease
Malú G. Tansey · University of Florida
2018 · research · Inflammation Biomarkers Program
Can Brain Inflammation Predict Dementia Associated with Parkinson's Disease?
Kathleen Lombard Poston · Stanford University
2018 · research · Target Advancement Program
Evaluating the Role and Therapeutic Potential of Natural Killer Cells in Parkinson's Disease
Jae-Kyung Lee · University of Georgia
2018 · research · Access to Data and Biospecimens
Interplay Between Microtubules, Alpha-synuclein and Inflammation as a Clue to Understanding and Managing Parkinson’s Disease
Massimiliano (Max) Bianchi · Transpharmation Ireland Limited
2018 · research · Improved Biomarkers and Clinical Outcome Measures
Expansion of Studies to Develop Tear Biomarkers of Parkinson's Disease
Sarah F. Hamm-Alvarez · University of Southern California
2018 · research · Target Advancement Program
Validating Astrocyte-produced Protein GDF15 as a Novel Neuroprotective Therapy
Lorraine Iacovitti · Thomas Jefferson University
2018 · research · Target Advancement Program
Testing the Ability of Clenbuterol to Prevent or Modify the Course of Parkinson's Disease
Joseph R. Patterson · Michigan State University